AI assistant
Sending…
VOLITIONRX LTD — Director's Dealing 2021
Jul 16, 2021
34395_dirs_2021-07-16_b3fa3489-544a-4bc7-b6f7-50eab3595a16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2021-07-14
Reporting Person: Rootsaert Rodney Gerard (Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-14 | Stock Option (Right to Buy) | $4 | D | 35000 | Disposed | 2021-07-23 | Common Stock (35000) | Direct |
| 2021-07-14 | Stock Option (Right to Buy) | $4 | A | 35000 | Acquired | 2025-07-23 | Common Stock (35000) | Direct |
Footnotes
F1: The reported transactions involved an amendment of outstanding options, resulting in the deemed cancellation of the "old" options and the grant of "replacement" options. The "old" options were originally granted on July 23, 2015, vested in full and were exercisable at 6 months from the date of grant, and as amended were exercisable for five years and six months from the date first exercisable. The "replacement" options are fully-vested and expire on July 23, 2025 (ten years from the date of grant).